147 related articles for article (PubMed ID: 6385429)
1. The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis.
Ellard GA
Tubercle; 1984 Sep; 65(3):211-27. PubMed ID: 6385429
[No Abstract] [Full Text] [Related]
2. Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.
Gurumurthy P; Krishnamurthy MS; Nazareth O; Parthasarathy R; Sarma GR; Somasundaram PR; Tripathy SP; Ellard GA
Am Rev Respir Dis; 1984 Jan; 129(1):58-61. PubMed ID: 6367570
[TBL] [Abstract][Full Text] [Related]
3. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
Ellard GA
Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
[TBL] [Abstract][Full Text] [Related]
4. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
Ellard GA
Cas Lek Cesk; 1984 Feb; 123(6):158-64. PubMed ID: 6697364
[No Abstract] [Full Text] [Related]
5. The incidence of the acetylator phenotype of isoniazid in healthy and in pulmonary tuberculosis subjects in Bihar.
Sinha CP; Sinha S; Sinha KP
J Assoc Physicians India; 1978 May; 26(5):353-60. PubMed ID: 730714
[No Abstract] [Full Text] [Related]
6. The hepatotoxicity of isoniazid among the three acetylator phenotypes.
Ellard GA; Girling DJ; Nunn AJ
Am Rev Respir Dis; 1981 May; 123(5):568-70. PubMed ID: 7235381
[No Abstract] [Full Text] [Related]
7. Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.
Ellard GA
Clin Pharmacol Ther; 1976 May; 19(5 Pt 2):610-25. PubMed ID: 773583
[TBL] [Abstract][Full Text] [Related]
8. Acetylation phenotype and hepatotoxicity in the treatment of tuberculosis in children.
Martinez-Roíg A; Camí J; Llorens-Terol J; de la Torre R; Perich F
Pediatrics; 1986 Jun; 77(6):912-5. PubMed ID: 3487069
[TBL] [Abstract][Full Text] [Related]
9. [Incidence of hepatic changes in relation to the isoniazid acetylator phenotype].
Pilheu JA; De Salvo MC; Manchinu I; de Negroni NR; Szemzo J
Medicina (B Aires); 1980; 40(4):382-6. PubMed ID: 7207170
[No Abstract] [Full Text] [Related]
10. [Clinical pharmacology of isoniazid (a review of the literature)].
Ivleva AIa
Probl Tuberk; 1979 Jan; (1):18-26. PubMed ID: 368763
[No Abstract] [Full Text] [Related]
11. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
Ylitalo P; Auterinen L; Marttinen A; Koivula T
Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
[TBL] [Abstract][Full Text] [Related]
12. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
Grönhagen-Riska C; Hellstrom PE; Fröseth B
Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].
Powłowska I; Rakowska Z
Pneumonol Pol; 1978 Aug; 46(8):605-12. PubMed ID: 714703
[No Abstract] [Full Text] [Related]
14. Determination of the isoniazid acetylator phenotype in a West African population.
Salako LA; Aderounmu AF
Tubercle; 1977 Jun; 58(2):109-12. PubMed ID: 878015
[TBL] [Abstract][Full Text] [Related]
15. Isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment.
Alarcón-Segovia D; Fishbein E; Alcalá H
Arthritis Rheum; 1971; 14(6):748-52. PubMed ID: 5316358
[No Abstract] [Full Text] [Related]
16. Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide.
Parthasarathy R; Sarma GR; Janardhanam B; Ramachandran P; Santha T; Sivasubramanian S; Somasundaram PR; Tripathy SP
Tubercle; 1986 Jun; 67(2):99-108. PubMed ID: 3775870
[TBL] [Abstract][Full Text] [Related]
17. Isoniazid acetylator phenotypes of Nigerians.
Afonja AO; Arhavwarien ED; Okotore RO; Femi-Pearse D
Niger Med J; 1979 Jan; 9(1):86-8. PubMed ID: 463346
[No Abstract] [Full Text] [Related]
18. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Singh SP; Pande JN; Khilnani GC; Kailash S
Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotype.
Yamamoto T; Suou T; Hirayama C
Hepatology; 1986; 6(2):295-8. PubMed ID: 3957235
[TBL] [Abstract][Full Text] [Related]
20. [Rate of acetylation of isoniazid in pulmonary tuberculosis and its relationship with effect and side-effects of treatment (author's transl)].
Zhang LX
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Dec; 4(6):349-51. PubMed ID: 7344873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
